Coronary metabolic adaptation restricted by endothelin in the dog heart

Acta Physiologica Hungarica

Volumn 88, Issue 1, 2001, Pages 35-46

  Fazekas, L ^a   Kékesi, Violetta ^a   Soos P ^a   Barát, Erzsébet ^b   Huszár, Éva ^b   Juhasz Nagy A ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b NATIONAL KORANYI INSTITUTE OF PULMONOLOGY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ANTIARRHYTHMIC AGENT; ENDOTHELIN 1; GLIBENCLAMIDE; INOSINE; POTASSIUM CHANNEL;

ADAPTATION; ANIMAL; ARTICLE; CORONARY ARTERY BLOOD FLOW; DOG; DRUG EFFECT; HEART MUSCLE; METABOLISM; VASOCONSTRICTION;

ADAPTATION, PHYSIOLOGICAL; ADENOSINE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; CORONARY CIRCULATION; DOGS; ENDOTHELIN-1; GLYBURIDE; INOSINE; MYOCARDIUM; POTASSIUM CHANNELS; VASOCONSTRICTION;

EID: 0035756119     PISSN: 0231424X     EISSN: None     Source Type: Journal    
DOI: 10.1556/APhysiol.88.2001.1.4     Document Type: Article

References (33)

1. 2 receptor mediated coronary vasodilatation in the dog. Cardiovasc. Res. 28, 906-911 (1994).
2. Aversano, T., Ouyang, P., Silverman, H.: Blockade of the ATP-sensitive potassium channel modulates reactive hyperemia in the canine coronary circulation. Circ. Res. 69, 618-622 (1991).
3. Belardinelli, L.: Adenosine system in the heart. Drug Dev. Res. 28, 263-267 (1993).
4. Belloni, F. L., Hintze, T. H.: Glibenclamide attenuates adenosine-induced bradycardia and coronary vasodilatation. Am. J. Physiol. 261, H720-H727 (1991).
5. + in cardiac cells? Cardiovasc. Res. 26, 433-442 (1992).
6. Clayton, F. C., Hess, T. A., Smith, M. A.: Coronary reactive hyperemia and adenosine-induced vasodilation are mediated partially by a glyburide-sensitive mechanism. Pharmacology 44, 92-100 (1992).
7. Daut, J., Maier-Rudolph, W., von-Beckerath, N., Mehrke, G., Gunther, K., Goedel-Meinen, L.: Hypoxic dilation of coronary arteries is mediated by ATP-sensitive potassium channels. Science 247, 1341-1344 (1990).
8. Eikens, E., Wilcken, D. E. L.: Myocardial reactive hyperemia and coronary vascular reactivity in the dog. Circ. Res. 33, 267-274 (1973).
9. Ely, S. W., Berne, R. M.: Protective effects of adenosine in myocardial ischemia. Circulation 85, 893-904 (1992).
10. ATP channels in the metabolic adaptation of the coronaries. Adv. Exp. Med. Biol. 471, 239-245 (1999).
11. Fazekas, L., Szabó, T., Barát, E., Huszár, É., Kékesi, V., Juhász-Nagy, A.: Compensation of endothelin-1-induced coronary vasoconstriction. J. Cardiovasc. Pharmacol. 31, S106-S108 (1998).
12. Feigl, E. O.: Coronary physiology. Physiol. Rev., 63, 1-205 (1983).
13. Hori, M., Kitakaze, M.: Adenosine, the heart, and coronary circulation. Hypertension 18, 565-574 (1991).
14. Huszár, É., Barát, E., Kollai, M.: Isocratic high-performance liquid chromatographic determination of plasma adenosine. Chromatographia 42, 318-322 (1996).
15. Juhász-Nagy, A., Kékesi, V., Fazekas, L.: Inosine-induced coronary vasodilation blocked by glibenclamide (abstract). J. Mol. Cell. Cardiol. 30, 137 (1998).
16. Juhász-Nagy, A., Kékesi, V., Fazekas, L., Merkely, B., Tóth, M.: Uneven flow distribution in the heart induced by endothelin. Adv. Exp. Med. Biol. 471, 247-256 (1999).
17. Kanatsuka, H., Sekiguchi, N., Sato, K., Akai, K., Wang, Y., Komaru, T., Ashikawa, K., Takishima, T.: Microvascular sites and mechanisms responsible for reactive hyperemia in the coronary circulation of the beating canine heart. Circ. Res. 71, 912-922 (1992).
18. Kaski, J. C., Elliott, P. M., Salomone, O., Dickinson, K., Gordon, D., Hann, C., Holt, D. W.: Concentration of circulating plasma endothelin in patients with angina and normal coronary angiograms. Br. Heart. J. 74, 620-624 (1995).
19. 2 receptors and cAMP-dependent protein kinase. Proc. Natl. Acad. Sci. USA 92, 12441-12445 (1995).
20. Koller, Á., Kaley, G.: Shear stress dependent regulation of vascular resistance in health and disease: role of endothelium. Endothelium 4, 247-272 (1996).
21. Matsuyama, K., Yasue, H., Okumura, K., Saito, Y., Nakao, K., Shirakami, G., Imura, H.: Increased plasma level of endothelin-1-like immunoreactivity during coronary spasm in patients with coronary spastic angina. Am. J. Cardiol. 68, 991-995 (1991).
22. + channels and depolarizes smooth muscle cells of porcine coronary artery. Circ. Res. 70, 612-616 (1992).
23. Mubagwa, K., Mullane, K., Flameng, W.: Role of adenosine in the heart and circulation. Cardiovasc. Res. 32, 797-813 (1996).
24. + channels in cardiac muscle. Nature 305, 147-148 (1983).
25. Obara, K., Hata, S., Sato, K., Koide, M., Ishii, K., Nakayama, K.: Contractile potentiation by endothelin-1 involves protein kinase C-δ activity in the porcine coronary artery. Jpn. J. Physiol. 49, 175-183 (1999).
26. Rubányi, G. M., Polokoff, M. A.: Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol. Rev. 46, 325-415 (1994).
27. Shryock, J. C., Belardinelli, L.: Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology. Am. J. Cardiol. 79(12A), 2-10 (1997).
28. Szabó, G., Fazekas, L., Bährle, S., MacDonald, D., Stumpf, N., Vahl, C. F., Hagl, S.: Endothelin-A and -B antagonists protect myocardial and endothelial function after ischemia/reperfusion in a rat heart transplantation model. Cardiovasc. Res. 39, 683-690 (1998).
29. Szokodi, I., Horkay, F., Merkely, B., Solti, F., Gellér, L., Kiss, P., Selmeci, L., Kékesi, V., Vuolteenaho, O., Leppäluoto, J., Ruskoaho, H., Juhász-Nagy, A., Tóth, M.: Intrapericardial infusion of endothelin-1 induces ventricular arrhythmias in dogs. Cardiovasc. Res. 38, 356-364 (1998).
30. Tóth, M., Kolossváry, E., Kékesi, V., Juhász-Nagy, A.: Subthreshold doses of endothelin attenuate the acetylcholine-induced coronary vasodilation in the dog (abstract). J. Vasc. Res. 29, 215 (1992).
31. Végh, Á., Parratt, J. R.: Ischaemic preconditioning markedly reduces the severity of ischaemia and reperfusion-induced arrhythmias; role of endogenous myocardial protective substances. In: Wainwright, C. L., Parratt, J. R. (eds): Myocardial Preconditioning, pp. 36-60. Springer Verlag, Berlin (1996).
32. + channels via pertussis-toxin-sensitive G-proteins. Cardiovasc. Res. 33, 123-130 (1997).
33. Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K., Masaki, T.: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332, 411-415 (1988).